首页 > 最新文献

European Journal of Cancer Prevention最新文献

英文 中文
To establish a prognostic model of epidermal growth factor receptor mutated non-small cell lung cancer patients based on Least Absolute Shrinkage and Selection Operator regression. 基于最小绝对收缩率和选择操作器回归,建立表皮生长因子受体突变非小细胞肺癌患者的预后模型。
IF 2.1 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-28 DOI: 10.1097/CEJ.0000000000000865
Bowen Li, Xiaopeng Zhang

Background: There is currently a shortage of effective diagnostic tools that are used for identifying long-term survival among non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. This research utilized the development of a prognostic model to assist clinicians in forecasting the survival over 24 months.

Methods: In Phase III and IV those patients who were diagnosed with EGFR mutation from January 2018 to June 2022 were enrolled into the lung cancer group of Thoracic Surgery Department of Hebei Provincial People's Hospital. Long-run survival was stated as survival for 24 months after being diagnosed. A multivariate prognostic pattern was constructed by means of internal validation and binary logistic regression by bootstrapping. One nomogram was created with a view to boosting the explanation and applicability of the pattern.

Results: A total of 603 patients with EGFR mutation were registered. Elements linked to the whole survival beyond 24 months were age (OR 6.15); female (OR 1.79); functional status (ECOG 0-1) (OR 5.26); Exon 20 insertion mutation deletion (OR 2.08); No central nervous system metastasis (OR 2.66), targeted therapy (OR 0.43); Immunotherapy (OR 0.24). The model has good internal validation.

Conclusion: Seven pretreatment clinicopathological variables predicted survival over 24 months. That pattern owns a great discriminative capability. It is hypothesized that this pattern is capable of assisting in selecting the optimal treatment sequence for NSCLC patients with EGFR mutations.

背景:目前缺乏有效的诊断工具来确定表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)患者的长期生存率。这项研究利用开发的预后模型来帮助临床医生预测 24 个月的生存率:方法:河北省人民医院胸外科肺癌组将2018年1月至2022年6月确诊为EGFR突变的III期和IV期患者纳入研究。长期生存期为确诊后24个月的生存期。通过内部验证和二元逻辑回归,并采用引导法,构建了多变量预后模式。为了增强该模式的解释性和适用性,还创建了一个提名图:结果:共登记了 603 例表皮生长因子受体突变患者。与超过 24 个月的总生存期相关的因素有:年龄(OR 6.15);女性(OR 1.79);功能状态(ECOG 0-1)(OR 5.26);外显子 20 插入突变缺失(OR 2.08);无中枢神经系统转移(OR 2.66);靶向治疗(OR 0.43);免疫治疗(OR 0.24)。该模型具有良好的内部验证性:结论:七个治疗前临床病理变量可预测 24 个月的生存率。该模式具有很强的判别能力。假设该模式能够帮助表皮生长因子受体(EGFR)突变的NSCLC患者选择最佳治疗顺序。
{"title":"To establish a prognostic model of epidermal growth factor receptor mutated non-small cell lung cancer patients based on Least Absolute Shrinkage and Selection Operator regression.","authors":"Bowen Li, Xiaopeng Zhang","doi":"10.1097/CEJ.0000000000000865","DOIUrl":"10.1097/CEJ.0000000000000865","url":null,"abstract":"<p><strong>Background: </strong>There is currently a shortage of effective diagnostic tools that are used for identifying long-term survival among non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. This research utilized the development of a prognostic model to assist clinicians in forecasting the survival over 24 months.</p><p><strong>Methods: </strong>In Phase III and IV those patients who were diagnosed with EGFR mutation from January 2018 to June 2022 were enrolled into the lung cancer group of Thoracic Surgery Department of Hebei Provincial People's Hospital. Long-run survival was stated as survival for 24 months after being diagnosed. A multivariate prognostic pattern was constructed by means of internal validation and binary logistic regression by bootstrapping. One nomogram was created with a view to boosting the explanation and applicability of the pattern.</p><p><strong>Results: </strong>A total of 603 patients with EGFR mutation were registered. Elements linked to the whole survival beyond 24 months were age (OR 6.15); female (OR 1.79); functional status (ECOG 0-1) (OR 5.26); Exon 20 insertion mutation deletion (OR 2.08); No central nervous system metastasis (OR 2.66), targeted therapy (OR 0.43); Immunotherapy (OR 0.24). The model has good internal validation.</p><p><strong>Conclusion: </strong>Seven pretreatment clinicopathological variables predicted survival over 24 months. That pattern owns a great discriminative capability. It is hypothesized that this pattern is capable of assisting in selecting the optimal treatment sequence for NSCLC patients with EGFR mutations.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"368-375"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tryptophan intake and pancreatic cancer: findings from a case-control study. 色氨酸摄入量与胰腺癌:一项病例对照研究的结果。
IF 2.1 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2024-01-15 DOI: 10.1097/CEJ.0000000000000864
Hung N Luu, Yen Thi-Hai Pham, Jian-Min Yuan, Randall E Brand, Tuyen Van Pham, Hang Viet Dao, Chung Kim Thi Le, Nhi Yen Ngoc Huynh, Hai Minh Nguyen, Ngoan Tran Le

Background: Pancreatic cancer is a leading cause of cancer-related death worldwide. Tryptophan plays a vital role in cell growth and maintenance as a building block of protein and coordination of organismal responses to environmental and dietary cues. Animal model study showed that dietary tryptophan improved treatment response in those who received chemotherapy or immune checkpoint inhibitors. Limited data are available assessing the association between tryptophan intake and risk of pancreatic cancer. We aimed to evaluate this association in a case-control study in Vietnam.

Methods: We analyzed data from a case-control study, including 3759 cancer cases and 2995 control subjects of whom 37 with pancreatic cancer cases. Tryptophan intake was derived from food frequency questionnaire. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for different levels of tryptophan intake with pancreatic cancer risk.

Results: Overall, tryptophan intake was inversely associated with pancreatic cancer risk in a dose-dependent manner. The ORs and 95% CIs of pancreatic cancer were 0.51 (0.29-0.92) for continuous scale, 0.27 (0.10-0.73) for tertile 2 and 0.34 (0.11-1.06) for tertile 3, compared with tertile 1 (the lowest intake) ( Ptrend = 0.02). In stratified analysis, this inverse association pattern was present among those with BMI < 23 kg/m 2 and ever drinkers.

Conclusion: A diet with a higher intake of tryptophan was significantly associated with a lower incidence of pancreatic cancer among Vietnamese population. These suggest that dietary modification may be an effective strategy for primary prevention of pancreatic cancer development.

背景:胰腺癌是全球癌症相关死亡的主要原因。色氨酸作为蛋白质的组成成分,在细胞生长和维持过程中发挥着重要作用,并能协调机体对环境和饮食线索的反应。动物模型研究表明,饮食中的色氨酸可改善接受化疗或免疫检查点抑制剂的患者的治疗反应。目前评估色氨酸摄入量与胰腺癌风险之间关系的数据有限。我们的目的是在越南的一项病例对照研究中评估这种关联:我们分析了一项病例对照研究的数据,包括 3759 例癌症病例和 2995 例对照受试者,其中 37 例为胰腺癌病例。色氨酸摄入量来自食物频率调查问卷。研究采用无条件逻辑回归法计算不同色氨酸摄入量与胰腺癌风险的几率比(ORs)和95%置信区间(CIs):结果:总体而言,色氨酸摄入量与胰腺癌风险成反比,且呈剂量依赖性。与三等分 1(最低摄入量)相比,连续分级的胰腺癌发生率和 95% CI 分别为 0.51(0.29-0.92),三等分 2 为 0.27(0.10-0.73),三等分 3 为 0.34(0.11-1.06)(Ptrend = 0.02)。在分层分析中,这种反向关联模式也出现在体重指数(BMI)为结论的人群中:在越南人群中,色氨酸摄入量较高的饮食与胰腺癌发病率较低明显相关。这表明,调整饮食可能是一级预防胰腺癌的有效策略。
{"title":"Tryptophan intake and pancreatic cancer: findings from a case-control study.","authors":"Hung N Luu, Yen Thi-Hai Pham, Jian-Min Yuan, Randall E Brand, Tuyen Van Pham, Hang Viet Dao, Chung Kim Thi Le, Nhi Yen Ngoc Huynh, Hai Minh Nguyen, Ngoan Tran Le","doi":"10.1097/CEJ.0000000000000864","DOIUrl":"10.1097/CEJ.0000000000000864","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer is a leading cause of cancer-related death worldwide. Tryptophan plays a vital role in cell growth and maintenance as a building block of protein and coordination of organismal responses to environmental and dietary cues. Animal model study showed that dietary tryptophan improved treatment response in those who received chemotherapy or immune checkpoint inhibitors. Limited data are available assessing the association between tryptophan intake and risk of pancreatic cancer. We aimed to evaluate this association in a case-control study in Vietnam.</p><p><strong>Methods: </strong>We analyzed data from a case-control study, including 3759 cancer cases and 2995 control subjects of whom 37 with pancreatic cancer cases. Tryptophan intake was derived from food frequency questionnaire. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for different levels of tryptophan intake with pancreatic cancer risk.</p><p><strong>Results: </strong>Overall, tryptophan intake was inversely associated with pancreatic cancer risk in a dose-dependent manner. The ORs and 95% CIs of pancreatic cancer were 0.51 (0.29-0.92) for continuous scale, 0.27 (0.10-0.73) for tertile 2 and 0.34 (0.11-1.06) for tertile 3, compared with tertile 1 (the lowest intake) ( Ptrend = 0.02). In stratified analysis, this inverse association pattern was present among those with BMI < 23 kg/m 2 and ever drinkers.</p><p><strong>Conclusion: </strong>A diet with a higher intake of tryptophan was significantly associated with a lower incidence of pancreatic cancer among Vietnamese population. These suggest that dietary modification may be an effective strategy for primary prevention of pancreatic cancer development.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"285-292"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139432240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction and validation of a nomogram prediction model for axillary lymph node metastasis of cT1 invasive breast cancer. cT1浸润性乳腺癌腋窝淋巴结转移nomogram预测模型的构建与验证。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-21 DOI: 10.1097/CEJ.0000000000000860
Shuqi Wang, Dongmo Wang, Xin Wen, Xiangli Xu, Dongmei Liu, Jiawei Tian

Objective: Based on the ultrasonic characteristics of the breast mass and axillary lymph nodes as well as the clinicopathological information, a model was developed for predicting axillary lymph node metastasis in cT1 breast cancer, and relevant features associated with axillary lymph node metastasis were identified.

Methods: Our retrospective study included 808 patients with cT1 invasive breast cancer treated at the Second Affiliated Hospital and the Cancer Hospital Affiliated with Harbin Medical University from February 2012 to August 2021 (250 cases in the positive axillary lymph node group and 558 cases in the negative axillary lymph node group). We allocated 564 cases to the training set and 244 cases to the verification set. R software was used to compare clinicopathological data and ultrasonic features between the two groups. Based on the results of multivariate logistic regression analysis, a nomogram prediction model was developed and verified for axillary lymph node metastasis of cT1 breast cancer.

Results: Univariate and multivariate logistic regression analysis indicated that palpable lymph nodes ( P  = 0.003), tumor location ( P  = 0.010), marginal contour ( P  < 0.001), microcalcification ( P  = 0.010), surrounding tissue invasion ( P  = 0.046), ultrasonic detection of lymph nodes ( P  = 0.001), cortical thickness ( P  < 0.001) and E-cadherin ( P  < 0.001) are independently associated with axillary lymph node metastasis. Using these features, a nomogram was developed for axillary lymph node metastasis. The training set had an area under the curve of 0.869, while the validation set had an area under the curve of 0.820. Based on the calibration curve, the model predicted axillary lymph node metastases were in good agreement with reality ( P  > 0.05). Nomogram's net benefit was good based on decision curve analysis.

Conclusion: The nomogram developed in this study has a high negative predictive value for axillary lymph node metastasis in invasive cT1 breast c ancer. Patients with no axillary lymph node metastases can be accurately screened using this nomogram, potentially allowing this group of patients to avoid invasive surgery.

目的:根据乳腺肿块及腋窝淋巴结的超声特征,结合临床病理资料,建立预测cT1乳腺癌腋窝淋巴结转移的模型,并识别与腋窝淋巴结转移相关的特征。方法:回顾性研究2012年2月至2021年8月在哈尔滨医科大学附属第二医院及肿瘤医院治疗的808例cT1浸润性乳腺癌患者(腋窝淋巴结阳性组250例,腋窝淋巴结阴性组558例)。我们将564个案例分配给训练集,244个案例分配给验证集。采用R软件比较两组患者的临床病理资料及超声特征。基于多因素logistic回归分析结果,建立并验证了cT1乳腺癌腋窝淋巴结转移的nomogram预测模型。结果:单因素和多因素logistic回归分析显示,可触及淋巴结(P = 0.003)、肿瘤位置(P = 0.010)、边缘轮廓(P 0.05)。决策曲线分析表明Nomogram净效益较好。结论:本研究建立的形态图对浸润性cT1型乳腺癌腋窝淋巴结转移具有较高的阴性预测价值。没有腋窝淋巴结转移的患者可以使用这种nomogram扫描图进行准确的筛查,从而有可能使这组患者避免进行侵入性手术。
{"title":"Construction and validation of a nomogram prediction model for axillary lymph node metastasis of cT1 invasive breast cancer.","authors":"Shuqi Wang, Dongmo Wang, Xin Wen, Xiangli Xu, Dongmei Liu, Jiawei Tian","doi":"10.1097/CEJ.0000000000000860","DOIUrl":"10.1097/CEJ.0000000000000860","url":null,"abstract":"<p><strong>Objective: </strong>Based on the ultrasonic characteristics of the breast mass and axillary lymph nodes as well as the clinicopathological information, a model was developed for predicting axillary lymph node metastasis in cT1 breast cancer, and relevant features associated with axillary lymph node metastasis were identified.</p><p><strong>Methods: </strong>Our retrospective study included 808 patients with cT1 invasive breast cancer treated at the Second Affiliated Hospital and the Cancer Hospital Affiliated with Harbin Medical University from February 2012 to August 2021 (250 cases in the positive axillary lymph node group and 558 cases in the negative axillary lymph node group). We allocated 564 cases to the training set and 244 cases to the verification set. R software was used to compare clinicopathological data and ultrasonic features between the two groups. Based on the results of multivariate logistic regression analysis, a nomogram prediction model was developed and verified for axillary lymph node metastasis of cT1 breast cancer.</p><p><strong>Results: </strong>Univariate and multivariate logistic regression analysis indicated that palpable lymph nodes ( P  = 0.003), tumor location ( P  = 0.010), marginal contour ( P  < 0.001), microcalcification ( P  = 0.010), surrounding tissue invasion ( P  = 0.046), ultrasonic detection of lymph nodes ( P  = 0.001), cortical thickness ( P  < 0.001) and E-cadherin ( P  < 0.001) are independently associated with axillary lymph node metastasis. Using these features, a nomogram was developed for axillary lymph node metastasis. The training set had an area under the curve of 0.869, while the validation set had an area under the curve of 0.820. Based on the calibration curve, the model predicted axillary lymph node metastases were in good agreement with reality ( P  > 0.05). Nomogram's net benefit was good based on decision curve analysis.</p><p><strong>Conclusion: </strong>The nomogram developed in this study has a high negative predictive value for axillary lymph node metastasis in invasive cT1 breast c ancer. Patients with no axillary lymph node metastases can be accurately screened using this nomogram, potentially allowing this group of patients to avoid invasive surgery.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"309-320"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138298748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of the prognostic value of serum carcinoembryonic antigen in patients with colorectal cancer liver metastases after hepatectomy. 血清癌胚抗原对结直肠癌肝切除术后肝转移患者预后价值的meta分析。
IF 2.1 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-13 DOI: 10.1097/CEJ.0000000000000859
Chenzhao Yuan, Lumin Zeng, Hongxiang Duan, Benjamas Suksatit

Objectives: Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker for differential diagnosis, monitoring, and response assessment of a variety of malignancies. This meta-analysis was aimed at evaluating whether serum CEA could predict the prognosis in patients with colorectal cancer liver metastasis (CRCLM) before and after liver resection (LR).

Methods: PubMed, Embase, Cochrane, and Web of Science were systematically searched to retrieve literature, with a search cutoff date of 27 February 2023. Articles were strictly screened for inclusion according to pre-specified inclusion and exclusion criteria. Data were pooled and analyzed using Stata 16.0.

Results: This meta-analysis included 36 studies involving a total of 11 143 CRCLM patients. The results showed that a high pre-LR serum CEA level was correlated with poor overall survival (OS: HR = 1.61, 95% CI = 1.49-1.75, P  < 0.001) and recurrence-free survival (RFS: HR = 1.27, 95% CI = 1.11-1.45, P  < 0.001) in CRCLM patients. A high post-LR serum CEA level predicted poor overall survival (OS: HR = 2.66, 95% CI = 2.10-3.38, P  < 0.001).

Conclusion: High preoperative and postoperative serum CEA levels in patients with CRCLM were significantly associated with poor prognosis, independent of treatment modality, mode of analysis, case origin, and cutoff value classification.

目的:癌胚抗原(CEA)是一种广谱肿瘤标志物,可用于多种恶性肿瘤的鉴别诊断、监测和反应评估。本荟萃分析旨在评估血清CEA是否可以预测肝切除(LR)前后结直肠癌肝转移(CRCLM)患者的预后。方法:系统检索PubMed、Embase、Cochrane和Web of Science,检索截止日期为2023年2月27日。根据预先指定的纳入和排除标准对纳入的文章进行严格筛选。使用Stata 16.0对数据进行汇总和分析。结果:本荟萃分析包括36项研究,共涉及11143例CRCLM患者。结果显示,lr前血清CEA水平高与总生存期差相关(OS: HR = 1.61, 95% CI = 1.49 ~ 1.75, P)。结论:CRCLM患者术前、术后血清CEA水平高与预后差显著相关,与治疗方式、分析方式、病例来源、截止值分类无关。
{"title":"Meta-analysis of the prognostic value of serum carcinoembryonic antigen in patients with colorectal cancer liver metastases after hepatectomy.","authors":"Chenzhao Yuan, Lumin Zeng, Hongxiang Duan, Benjamas Suksatit","doi":"10.1097/CEJ.0000000000000859","DOIUrl":"10.1097/CEJ.0000000000000859","url":null,"abstract":"<p><strong>Objectives: </strong>Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker for differential diagnosis, monitoring, and response assessment of a variety of malignancies. This meta-analysis was aimed at evaluating whether serum CEA could predict the prognosis in patients with colorectal cancer liver metastasis (CRCLM) before and after liver resection (LR).</p><p><strong>Methods: </strong>PubMed, Embase, Cochrane, and Web of Science were systematically searched to retrieve literature, with a search cutoff date of 27 February 2023. Articles were strictly screened for inclusion according to pre-specified inclusion and exclusion criteria. Data were pooled and analyzed using Stata 16.0.</p><p><strong>Results: </strong>This meta-analysis included 36 studies involving a total of 11 143 CRCLM patients. The results showed that a high pre-LR serum CEA level was correlated with poor overall survival (OS: HR = 1.61, 95% CI = 1.49-1.75, P  < 0.001) and recurrence-free survival (RFS: HR = 1.27, 95% CI = 1.11-1.45, P  < 0.001) in CRCLM patients. A high post-LR serum CEA level predicted poor overall survival (OS: HR = 2.66, 95% CI = 2.10-3.38, P  < 0.001).</p><p><strong>Conclusion: </strong>High preoperative and postoperative serum CEA levels in patients with CRCLM were significantly associated with poor prognosis, independent of treatment modality, mode of analysis, case origin, and cutoff value classification.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"334-346"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138298750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary prevention of HPV-related diseases from the patients' perspective in Poland. 从波兰患者的角度看人乳头瘤病毒相关疾病的初级预防。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-30 DOI: 10.1097/CEJ.0000000000000866
Dominika Trojnarska, Robert Jach

Objectives: This study aimed to assess the knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination (HPVv) among female patients in Poland, investigating the impact of sociodemographic factors on these aspects. The study also explored awareness of state-funded bivalent vaccination and gauged willingness to vaccinate children, especially in the aspect of the newly introduced nonavalent vaccine.

Material and methods: An 11-question questionnaire was administered to newly referred patients at a dysplasia consultation center in Kraków University Hospital between February and December 2022. Statistical analysis using IBM SPSS Statistics 25 evaluated sociodemographic characteristics, HPV knowledge, attitudes toward HPVv and correlations among responses.

Results: By December 2022, 187 completed forms were received, primarily from women aged 30-40 years, residing in large cities, and with higher education qualifications. While most were aware of HPV's association with cancer and abnormal cytology, over 40% were unaware of its asymptomatic nature. Higher education is correlated with better HPV awareness. Participants generally showed positive attitudes toward HPVv for themselves and their children, yet only a small fraction had received the vaccine. Education significantly influenced HPV knowledge, with higher education levels linked to better awareness and willingness to vaccinate children. Awareness of HPV is positively correlated with knowledge test performance and vaccination attitudes.

Conclusion: The study revealed a lack of awareness regarding government co-financing for the bivalent vaccine. Campaigns endorsing reimbursed vaccination were found to be inadequate, highlighting the need for corrective measures to enhance awareness and improve vaccination rates, particularly for individuals outside the age range between 12 and 13 years relying on self-financing or sporadic government initiatives.

研究目的本研究旨在评估波兰女性患者对人类乳头瘤病毒 (HPV) 的了解程度以及对接种 HPV 疫苗 (HPVv) 的态度,并调查社会人口因素对这些方面的影响。研究还探讨了对国家资助的二价疫苗接种的认识,并衡量了为儿童接种疫苗的意愿,尤其是在新引入的无价疫苗方面:在 2022 年 2 月至 12 月期间,对克拉科夫大学医院发育不良咨询中心的新转诊患者进行了 11 个问题的问卷调查。使用 IBM SPSS Statistics 25 进行统计分析,评估了社会人口学特征、HPV 知识、对 HPVv 的态度以及回答之间的相关性:截至 2022 年 12 月,共收到 187 份填写完整的表格,主要来自 30-40 岁、居住在大城市、受过高等教育的女性。虽然大多数人都知道人乳头瘤病毒与癌症和异常细胞学检查有关,但超过 40% 的人不知道人乳头瘤病毒无症状的特性。受教育程度越高,对 HPV 的认知度越高。参与者普遍对自己及其子女接种人乳头瘤病毒疫苗持积极态度,但只有一小部分人接种过疫苗。教育程度对 HPV 知识的影响很大,教育程度越高,对 HPV 的认知度越高,也更愿意为孩子接种疫苗。对人类乳头瘤病毒的认识与知识测试成绩和疫苗接种态度呈正相关:研究表明,人们对政府共同资助二价疫苗缺乏认识。研究发现,支持有偿疫苗接种的宣传活动并不充分,这突出表明有必要采取纠正措施,以增强人们的意识并提高疫苗接种率,尤其是对于依赖自筹资金或零星政府举措的 12 至 13 岁年龄段以外的人群。
{"title":"Primary prevention of HPV-related diseases from the patients' perspective in Poland.","authors":"Dominika Trojnarska, Robert Jach","doi":"10.1097/CEJ.0000000000000866","DOIUrl":"10.1097/CEJ.0000000000000866","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination (HPVv) among female patients in Poland, investigating the impact of sociodemographic factors on these aspects. The study also explored awareness of state-funded bivalent vaccination and gauged willingness to vaccinate children, especially in the aspect of the newly introduced nonavalent vaccine.</p><p><strong>Material and methods: </strong>An 11-question questionnaire was administered to newly referred patients at a dysplasia consultation center in Kraków University Hospital between February and December 2022. Statistical analysis using IBM SPSS Statistics 25 evaluated sociodemographic characteristics, HPV knowledge, attitudes toward HPVv and correlations among responses.</p><p><strong>Results: </strong>By December 2022, 187 completed forms were received, primarily from women aged 30-40 years, residing in large cities, and with higher education qualifications. While most were aware of HPV's association with cancer and abnormal cytology, over 40% were unaware of its asymptomatic nature. Higher education is correlated with better HPV awareness. Participants generally showed positive attitudes toward HPVv for themselves and their children, yet only a small fraction had received the vaccine. Education significantly influenced HPV knowledge, with higher education levels linked to better awareness and willingness to vaccinate children. Awareness of HPV is positively correlated with knowledge test performance and vaccination attitudes.</p><p><strong>Conclusion: </strong>The study revealed a lack of awareness regarding government co-financing for the bivalent vaccine. Campaigns endorsing reimbursed vaccination were found to be inadequate, highlighting the need for corrective measures to enhance awareness and improve vaccination rates, particularly for individuals outside the age range between 12 and 13 years relying on self-financing or sporadic government initiatives.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"299-308"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138797805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors of diabetes and cancer-specific mortalities in patients with infiltrating ductal carcinoma of the breast: a population-based study. 乳腺浸润性导管癌患者的糖尿病风险因素和癌症特异性死亡率:一项基于人群的研究。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-12-27 DOI: 10.1097/CEJ.0000000000000869
Alaa Ahmed Elshanbary, Mohamed Sayed Zaazouee, Anas Zakarya Nourelden, Mohammed Al-Kafarna, Sajeda Ghassan Matar, Ahmed Saad Elsaeidy, Khaled Mohamed Ragab, Mahmoud M Elhady, Ghadeer M Albadrani, Ahmed E Altyar, Osama A Kensara, Mohamed M Abdel-Daim

Background and aims: Breast cancer is considered one of the most common neoplasms worldwide. Diabetes (DM) increases mortality among postmenopausal patients with breast cancer. Our study aims to identify the risk factors of DM-specific mortality and infiltrating ductal carcinoma (IDC) mortality in patients with IDC of the breast.

Materials and methods: Data of IDC patients were obtained from the Surveillance, Epidemiology, and End Results database from 1975 to 2016. Independent variables included age, race, marital status, the primary site of IDC, breast subtype, the disease stage, grade, chemotherapy, radiation, and surgery. Kaplan-Meier, Cox and Binary regression tests were used to analyze the data using SPSS software.

Results: A total of 673 533 IDC patients were analyzed. Of them, 4224 died due to DM and 116 822 died due to IDC. Factors that increase the risk of overall, IDC-specific, and DM-specific mortalities include older age, black race, widowed, uninsured, regional and distant stages, grade II and III, and no treatment with chemotherapy or radiotherapy or surgery. Additionally, the IDC mortality increased with separated status, all primary sites, all breast subtypes, and stage IV.

Conclusion: In patients with IDC, controlling DM besides cancer is recommended to reduce the mortality risk. Old, black, widowed, uninsured, regional and distant stages, grade II and III, and no treatment are common risk factors for DM- and IDC-mortality.

背景和目的:乳腺癌被认为是全球最常见的肿瘤之一。糖尿病(DM)会增加绝经后乳腺癌患者的死亡率。我们的研究旨在确定DM特异性死亡率和乳腺IDC患者浸润性导管癌(IDC)死亡率的风险因素:IDC患者的数据来自1975年至2016年的监测、流行病学和最终结果数据库。自变量包括年龄、种族、婚姻状况、IDC的原发部位、乳腺亚型、疾病分期、分级、化疗、放疗和手术。采用SPSS软件对数据进行卡普兰-梅耶检验、考克斯检验和二元回归检验:结果:共分析了 673 533 例 IDC 患者。结果:共分析了 673 533 例 IDC 患者,其中 4224 例死于 DM,116 822 例死于 IDC。增加总死亡风险、IDC特异性死亡风险和DM特异性死亡风险的因素包括:年龄较大、黑人、丧偶、无保险、区域和远处分期、II级和III级、未接受化疗、放疗或手术治疗。此外,IDC死亡率随分居状态、所有原发部位、所有乳腺亚型和IV期而增加:结论:对于IDC患者,建议在治疗癌症的同时控制糖尿病,以降低死亡风险。老年、黑人、丧偶、无保险、区域和远处分期、II级和III级以及未接受治疗是导致DM和IDC死亡的常见风险因素。
{"title":"Risk factors of diabetes and cancer-specific mortalities in patients with infiltrating ductal carcinoma of the breast: a population-based study.","authors":"Alaa Ahmed Elshanbary, Mohamed Sayed Zaazouee, Anas Zakarya Nourelden, Mohammed Al-Kafarna, Sajeda Ghassan Matar, Ahmed Saad Elsaeidy, Khaled Mohamed Ragab, Mahmoud M Elhady, Ghadeer M Albadrani, Ahmed E Altyar, Osama A Kensara, Mohamed M Abdel-Daim","doi":"10.1097/CEJ.0000000000000869","DOIUrl":"10.1097/CEJ.0000000000000869","url":null,"abstract":"<p><strong>Background and aims: </strong>Breast cancer is considered one of the most common neoplasms worldwide. Diabetes (DM) increases mortality among postmenopausal patients with breast cancer. Our study aims to identify the risk factors of DM-specific mortality and infiltrating ductal carcinoma (IDC) mortality in patients with IDC of the breast.</p><p><strong>Materials and methods: </strong>Data of IDC patients were obtained from the Surveillance, Epidemiology, and End Results database from 1975 to 2016. Independent variables included age, race, marital status, the primary site of IDC, breast subtype, the disease stage, grade, chemotherapy, radiation, and surgery. Kaplan-Meier, Cox and Binary regression tests were used to analyze the data using SPSS software.</p><p><strong>Results: </strong>A total of 673 533 IDC patients were analyzed. Of them, 4224 died due to DM and 116 822 died due to IDC. Factors that increase the risk of overall, IDC-specific, and DM-specific mortalities include older age, black race, widowed, uninsured, regional and distant stages, grade II and III, and no treatment with chemotherapy or radiotherapy or surgery. Additionally, the IDC mortality increased with separated status, all primary sites, all breast subtypes, and stage IV.</p><p><strong>Conclusion: </strong>In patients with IDC, controlling DM besides cancer is recommended to reduce the mortality risk. Old, black, widowed, uninsured, regional and distant stages, grade II and III, and no treatment are common risk factors for DM- and IDC-mortality.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"321-333"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center. 简化结直肠癌患者林奇综合征的诊断路径:意大利一家癌症中心的十年经验。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2024-01-09 DOI: 10.1097/CEJ.0000000000000870
Alberto Puccini, Simone Nardin, Lucia Trevisan, Sonia Lastraioli, Viviana Gismondi, Ilaria Ricciotti, Azzurra Damiani, Giacomo Bregni, Roberto Murialdo, Alessandro Pastorino, Valentino Martelli, Annalice Gandini, Luca Mastracci, Liliana Varesco, Maria Dono, Linda Battistuzzi, Federica Grillo, Stefania Sciallero

Background: Universal screening of colorectal cancer (CRC) patients for Lynch syndrome (LS) through MisMatch Repair (MMR) testing is recommended. BRAF V600E mutation and/or MLH1 promoter methylation (Reflex Testing, RefT)generally rule out LS in MLH1-deficient (dMLH1) patients. We estimated the impact of RefTon genetic counseling (GC) and on the diagnostic yield of genetic testing (GT).

Methods: Overall, 3199 CRC patients were referred to our center between 2011 and 2021. Patients referred until January 2019 (n=2536) underwent universal MMR testing and were termed 'Cohort A'; among patients after February 2019 (n=663), 'Cohort B', RefT was also performed in dMLH1 patients.

Results: Overall, 401/3199 patients (12.5%) were MMR-deficient (dMMR); 312 (77.8%) in cohort A and 89 (22.2%) inB; 346/401 were dMLH1 (86.3%), 262/312 (83.9%) in cohort A and 84/89 (94.3%) in B. In Cohort A, 91/312 (29.1%) dMMR patients were referred to GC, 69/91 (75.8%) were in the dMLH1 group; 57/69 (82.6%) dMLH1 patients underwent GT and 1/57 (1.7%) had LS. In Cohort B, 3/84 dMLH1 patients did not undergo BRAF testing. Three BRAF wt and not hypermethylated of the remaining 81 dMLH1 patients were referred to GC and GT, and one had LS. This diagnostic pathway reduced GC referrals by 96% (78/81) in Cohort B and increased the diagnostic yield of GT by about 20 times.

Conclusion: Our findings support RefT in dMLH1 CRC patients within the LS diagnostic pathway, as it reduces the number of GC sessions needed and increases the diagnostic yield of GT.

背景:建议通过错配修补(MMR)检测对结直肠癌(CRC)患者进行林奇综合征(LS)普查。BRAFV600E突变和/或MLH1启动子甲基化(反射检测,RefT)通常可排除MLH1缺陷(dMLH1)患者的LS。我们估算了 RefT 对遗传咨询(GC)和遗传检测(GT)诊断率的影响:2011年至2021年间,共有3199名CRC患者转诊至本中心。2019年1月之前转诊的患者(n=2536)接受了MMR通用检测,被称为 "队列A";2019年2月之后的患者(n=663)被称为 "队列B",对dMLH1患者也进行了RefT:总体而言,401/3199 例患者(12.5%)为 MMR 缺乏(dMMR),A 组群中有 312 例(77.8%),B 组群中有 89 例(22.2%);346/401 例患者为 dMLH1(86.3%),A 组群中有 262/312 例(83.9%),B 组群中有 84/89 例(94.3%)。在队列 A 中,91/312(29.1%)名 dMMR 患者被转至 GC,69/91(75.8%)名 dMLH1 组;57/69(82.6%)名 dMLH1 患者接受了 GT,1/57(1.7%)名患者接受了 LS。在队列 B 中,3/84 的 dMLH1 患者没有接受 BRAF 检测。剩余的 81 名 dMLH1 患者中,有 3 名 BRAF 含量为 wt 且未发生高甲基化的患者被转诊至 GC 和 GT,1 名患者进行了 LS。在队列 B 中,这种诊断途径将 GC 转诊率降低了 96%(78/81),并将 GT 的诊断率提高了约 20 倍:我们的研究结果支持在 LS 诊断路径下对 dMLH1 CRC 患者进行 RefT,因为它减少了所需的 GC 治疗次数,提高了 GT 的诊断率。
{"title":"Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.","authors":"Alberto Puccini, Simone Nardin, Lucia Trevisan, Sonia Lastraioli, Viviana Gismondi, Ilaria Ricciotti, Azzurra Damiani, Giacomo Bregni, Roberto Murialdo, Alessandro Pastorino, Valentino Martelli, Annalice Gandini, Luca Mastracci, Liliana Varesco, Maria Dono, Linda Battistuzzi, Federica Grillo, Stefania Sciallero","doi":"10.1097/CEJ.0000000000000870","DOIUrl":"10.1097/CEJ.0000000000000870","url":null,"abstract":"<p><strong>Background: </strong>Universal screening of colorectal cancer (CRC) patients for Lynch syndrome (LS) through MisMatch Repair (MMR) testing is recommended. BRAF V600E mutation and/or MLH1 promoter methylation (Reflex Testing, RefT)generally rule out LS in MLH1-deficient (dMLH1) patients. We estimated the impact of RefTon genetic counseling (GC) and on the diagnostic yield of genetic testing (GT).</p><p><strong>Methods: </strong>Overall, 3199 CRC patients were referred to our center between 2011 and 2021. Patients referred until January 2019 (n=2536) underwent universal MMR testing and were termed 'Cohort A'; among patients after February 2019 (n=663), 'Cohort B', RefT was also performed in dMLH1 patients.</p><p><strong>Results: </strong>Overall, 401/3199 patients (12.5%) were MMR-deficient (dMMR); 312 (77.8%) in cohort A and 89 (22.2%) inB; 346/401 were dMLH1 (86.3%), 262/312 (83.9%) in cohort A and 84/89 (94.3%) in B. In Cohort A, 91/312 (29.1%) dMMR patients were referred to GC, 69/91 (75.8%) were in the dMLH1 group; 57/69 (82.6%) dMLH1 patients underwent GT and 1/57 (1.7%) had LS. In Cohort B, 3/84 dMLH1 patients did not undergo BRAF testing. Three BRAF wt and not hypermethylated of the remaining 81 dMLH1 patients were referred to GC and GT, and one had LS. This diagnostic pathway reduced GC referrals by 96% (78/81) in Cohort B and increased the diagnostic yield of GT by about 20 times.</p><p><strong>Conclusion: </strong>Our findings support RefT in dMLH1 CRC patients within the LS diagnostic pathway, as it reduces the number of GC sessions needed and increases the diagnostic yield of GT.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"355-362"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139402414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer worry at higher-risk sample of hereditary cancer in Spain. 西班牙人对遗传性癌症高风险样本的担忧。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-07-01 Epub Date: 2023-11-13 DOI: 10.1097/CEJ.0000000000000862
Gema Costa-Requena, Paula Richart-Aznar, Ángel Segura-Huerta

Background: Few studies have examined the prevalence of cancer worry in the general and at-risk population. The objective of this study was to describe the prevalence of cancer worry in a sample of individuals at increased risk of developing hereditary cancer, determine differences in cancer worry by socio-demographic characteristics and assess the relationship between cancer worry and psychological distress.

Methods: A cross-sectional study was designed with 895 patients. The Cancer Worry Scale (CWS), Hospital Anxiety and Depression Scale (HADS) for psychological distress and sociodemographic characteristics were examined. The multiple linear regression model was developed to explore what variables were predicted for cancer worry. To identify variables associated with higher cancer worry scores, a logistic model was fitted.

Results: In the at-higher-risk sample of hereditary cancer, the mean of CWS was 10.20 (SD: 3.70). The significant predictors for cancer worry were gender, age, previous psychiatric treatment, patients affected by cancer and having children. In the sample, 38% of patients had higher scores on cancer worry, the variables associated were patients affected by cancer compared, women, widow/divorced participants, less than secondary school, patients with previous psychiatric treatment and patients less than 55 years old. Using the HADS cutoff score 29% of the sample showed significant psychological distress, more anxiety (35%) than depressive (22%) symptomatology. Psychological distress showed a higher variability (36%) on cancer worry.

Conclusion: Findings highlighted distinctive profiles in socio-demographic characteristics according to the degree of cancer worry; therefore, genetic counseling should continue to be provided to address cancer worry and relieve psychological distress.

背景:很少有研究调查了普通人群和高危人群对癌症的担忧程度。本研究的目的是描述患遗传性癌症风险增加的个体样本中癌症担忧的患病率,通过社会人口统计学特征确定癌症担忧的差异,并评估癌症担忧与心理困扰之间的关系。方法:对895例患者进行横断面研究。采用癌症焦虑量表(CWS)、医院焦虑抑郁量表(HADS)评估心理困扰和社会人口学特征。建立多元线性回归模型,探讨哪些变量可以预测癌症担忧。为了确定与较高的癌症担忧得分相关的变量,我们拟合了一个逻辑模型。结果:在遗传癌高危人群中,CWS平均值为10.20 (SD: 3.70)。癌症担忧的重要预测因素是性别、年龄、以前的精神治疗、受癌症影响的患者和是否有孩子。在样本中,38%的患者在癌症担忧方面得分较高,相关变量包括受癌症影响的患者、女性、寡妇/离婚的参与者、中学以下学历的患者、之前接受过精神治疗的患者以及年龄小于55岁的患者。使用HADS临界值,29%的样本表现出明显的心理困扰,焦虑(35%)多于抑郁(22%)的症状。心理困扰对癌症的担忧表现出更高的可变性(36%)。结论:研究结果突出了不同癌症担忧程度的社会人口学特征的不同特征;因此,应继续提供遗传咨询,以解决癌症担忧,缓解心理困扰。
{"title":"Cancer worry at higher-risk sample of hereditary cancer in Spain.","authors":"Gema Costa-Requena, Paula Richart-Aznar, Ángel Segura-Huerta","doi":"10.1097/CEJ.0000000000000862","DOIUrl":"10.1097/CEJ.0000000000000862","url":null,"abstract":"<p><strong>Background: </strong>Few studies have examined the prevalence of cancer worry in the general and at-risk population. The objective of this study was to describe the prevalence of cancer worry in a sample of individuals at increased risk of developing hereditary cancer, determine differences in cancer worry by socio-demographic characteristics and assess the relationship between cancer worry and psychological distress.</p><p><strong>Methods: </strong>A cross-sectional study was designed with 895 patients. The Cancer Worry Scale (CWS), Hospital Anxiety and Depression Scale (HADS) for psychological distress and sociodemographic characteristics were examined. The multiple linear regression model was developed to explore what variables were predicted for cancer worry. To identify variables associated with higher cancer worry scores, a logistic model was fitted.</p><p><strong>Results: </strong>In the at-higher-risk sample of hereditary cancer, the mean of CWS was 10.20 (SD: 3.70). The significant predictors for cancer worry were gender, age, previous psychiatric treatment, patients affected by cancer and having children. In the sample, 38% of patients had higher scores on cancer worry, the variables associated were patients affected by cancer compared, women, widow/divorced participants, less than secondary school, patients with previous psychiatric treatment and patients less than 55 years old. Using the HADS cutoff score 29% of the sample showed significant psychological distress, more anxiety (35%) than depressive (22%) symptomatology. Psychological distress showed a higher variability (36%) on cancer worry.</p><p><strong>Conclusion: </strong>Findings highlighted distinctive profiles in socio-demographic characteristics according to the degree of cancer worry; therefore, genetic counseling should continue to be provided to address cancer worry and relieve psychological distress.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"293-298"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138298746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediterranean diet and colorectal adenomas: a systematic review and meta-analysis of observational studies. 地中海饮食与结直肠腺瘤:观察性研究的系统综述和荟萃分析。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-05-01 Epub Date: 2023-11-06 DOI: 10.1097/CEJ.0000000000000861
Saeede Jafari Nasab, Cain C T Clark, Mohammadhasan Entezari

Colorectal adenomas (CRAs) are epithelial lesions of the large bowel that can develop into colorectal cancer. Some studies have shown an inverse association of the Mediterranean diet (MED) with adenoma, but the extent of the association is equivocal. Owing to the lack of meta-analytical evidence in the literature, we sought to assess the association between MED and CRAs by conducting a systematic review and meta-analysis. A comprehensive systematic literature search of observational studies was conducted via PubMed, Scopus, Google Scholar and Web of Sciences up to May 2023. Studies were included in our review if they evaluated the association between MED and CRA, following an observational study design. Six studies were included in this study. We found that adherence to MED was inversely associated with CRA risk (odds ratio, 0.79; confidence interval, 0.73-0.85); implying that higher adherence to MED could reduce the risk of CRA by ~21%. Stratification by the year of studies, sex, study design, country and exposure showed a significant association between MED and CRA. The results of the current study provide evidence of an inverse association between adherence to MED and CRAs.

结直肠腺瘤(CRAs)是大肠上皮病变,可发展为结直肠癌癌症。一些研究表明地中海饮食(MED)与腺瘤呈负相关,但这种相关性的程度尚不明确。由于文献中缺乏荟萃分析证据,我们试图通过进行系统综述和荟萃分析来评估MED和CRA之间的关联。截至2023年5月,通过PubMed、Scopus、Google Scholar和Web of Sciences对观察性研究进行了全面、系统的文献检索。根据观察性研究设计,如果研究评估了MED和CRA之间的相关性,则将其纳入我们的综述。本研究包括六项研究。我们发现,坚持MED与CRA风险呈负相关(比值比为0.79;置信区间为0.73-0.85);这意味着对MED的更高依从性可以将CRA的风险降低约21%。按研究年份、性别、研究设计、国家和接触情况进行的分层显示,MED和CRA之间存在显著关联。目前的研究结果提供了MED依从性和CRA之间存在反向关联的证据。
{"title":"Mediterranean diet and colorectal adenomas: a systematic review and meta-analysis of observational studies.","authors":"Saeede Jafari Nasab, Cain C T Clark, Mohammadhasan Entezari","doi":"10.1097/CEJ.0000000000000861","DOIUrl":"10.1097/CEJ.0000000000000861","url":null,"abstract":"<p><p>Colorectal adenomas (CRAs) are epithelial lesions of the large bowel that can develop into colorectal cancer. Some studies have shown an inverse association of the Mediterranean diet (MED) with adenoma, but the extent of the association is equivocal. Owing to the lack of meta-analytical evidence in the literature, we sought to assess the association between MED and CRAs by conducting a systematic review and meta-analysis. A comprehensive systematic literature search of observational studies was conducted via PubMed, Scopus, Google Scholar and Web of Sciences up to May 2023. Studies were included in our review if they evaluated the association between MED and CRA, following an observational study design. Six studies were included in this study. We found that adherence to MED was inversely associated with CRA risk (odds ratio, 0.79; confidence interval, 0.73-0.85); implying that higher adherence to MED could reduce the risk of CRA by ~21%. Stratification by the year of studies, sex, study design, country and exposure showed a significant association between MED and CRA. The results of the current study provide evidence of an inverse association between adherence to MED and CRAs.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"223-231"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers. 嘌呤能配体门控离子通道7受体在常见消化系统癌症中的作用。
IF 2.4 4区 医学 Q3 ONCOLOGY Pub Date : 2024-05-01 Epub Date: 2023-11-06 DOI: 10.1097/CEJ.0000000000000851
Xin Wang, Qingqing Yu, Xue Bai, Xinyu Li, Yanli Sun, Xiaoxiang Peng, Ronglan Zhao

The incidence of digestive malignancies has increased in recent years, including colorectal cancer (CRC), hepatocellular carcinoma (HCC) and pancreatic cancer. Advanced stages of these cancers are prone to metastasis, which seriously reduce the standard of living of patients and lead to decline in the survival rate of patients. So far there are no good specific drugs to stop this phenomenon. It is very important and urgent to find new biomarkers and therapeutic targets. Purinergic ligand-gated ion channel 7 receptor (P2X7R) is ATP-gated and nonselective ion channel receptor involved in many inflammatory processes and cancer progression. P2X7R is present in many cancer cells and promotes or inhibits cancer development through signal transduction. Studies have presented that P2X7R plays a role in the proliferation and migration of digestive system cancers, such as CRC, HCC and pancreatic cancer. Therefore, P2X7R may serve as a biomarker or therapeutic target for digestive system cancers. This paper describes the structure and function of P2X7R, and mainly reviews the research progress on the role of P2X7R in CRC, HCC and pancreatic cancer.

近年来,消化系统恶性肿瘤的发病率有所上升,包括结直肠癌(CRC)、肝细胞癌(HCC)和癌症。这些癌症的晚期容易发生转移,严重降低了患者的生活水平,导致患者的生存率下降。到目前为止,还没有好的特效药来阻止这种现象。寻找新的生物标志物和治疗靶点是非常重要和紧迫的。嘌呤能连接物门控离子通道7受体(P2X7R)是一种ATP-门控非选择性离子通道受体,参与许多炎症过程和癌症进展。P2X7R存在于许多癌症细胞中,并通过信号传导促进或抑制癌症的发展。研究表明,P2X7R在消化系统癌症(如CRC、HCC和癌症)的增殖和迁移中发挥作用。因此,P2X7R可以作为消化系统癌症的生物标志物或治疗靶点。本文介绍了P2X7R的结构和功能,重点综述了P2X7R在结直肠癌、肝癌和癌症中的作用研究进展。
{"title":"The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.","authors":"Xin Wang, Qingqing Yu, Xue Bai, Xinyu Li, Yanli Sun, Xiaoxiang Peng, Ronglan Zhao","doi":"10.1097/CEJ.0000000000000851","DOIUrl":"10.1097/CEJ.0000000000000851","url":null,"abstract":"<p><p>The incidence of digestive malignancies has increased in recent years, including colorectal cancer (CRC), hepatocellular carcinoma (HCC) and pancreatic cancer. Advanced stages of these cancers are prone to metastasis, which seriously reduce the standard of living of patients and lead to decline in the survival rate of patients. So far there are no good specific drugs to stop this phenomenon. It is very important and urgent to find new biomarkers and therapeutic targets. Purinergic ligand-gated ion channel 7 receptor (P2X7R) is ATP-gated and nonselective ion channel receptor involved in many inflammatory processes and cancer progression. P2X7R is present in many cancer cells and promotes or inhibits cancer development through signal transduction. Studies have presented that P2X7R plays a role in the proliferation and migration of digestive system cancers, such as CRC, HCC and pancreatic cancer. Therefore, P2X7R may serve as a biomarker or therapeutic target for digestive system cancers. This paper describes the structure and function of P2X7R, and mainly reviews the research progress on the role of P2X7R in CRC, HCC and pancreatic cancer.</p>","PeriodicalId":11830,"journal":{"name":"European Journal of Cancer Prevention","volume":" ","pages":"271-281"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Cancer Prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1